Latest Breaking News On - Chris fair - Page 1 : comparemela.com

Kuros Biosciences : Minutes of AGM, 17 April 2024

MINUTES of the 26th Annual General Meeting of KUROS BIOSCIENCES LTD held.

United statesMatthias staehelinOliver walkerDaniel geigerThomas ebingerAlbert arpRaphael kellerClemens van blitterswijkRemuneration committeeArticles of associationKuros biosciences ltdCredit suisseElection of the compensation committeeMembers of the executive committeePricewaterhousecoopers ltdCompensation for members of the executive committee

Kuros Biosciences AG: Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales

Kuros Biosciences AG: Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesG joseph joe rossVan dijkKuros biosciencesDaniel geigerDennis riedlBusiness developmentSwiss exchangeKuros leadership teamLeadership teamDrug administrationKuros medical devicesMedical devicesMagnetos puttySenior vice president marketingJoe ross

Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales

Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesG joseph joe rossVan dijkKuros biosciencesBusiness developmentSwiss exchangeKuros leadership teamLeadership teamDrug administrationKuros medical devicesMedical devicesMagnetos puttySenior vice president marketingJoe rossSenior vice presidentChris fair

Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales - adhoc - Börsennachrichten

Kuros Biosciences AG Key word Quarter ResultsRegulatory Approval Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales 24Apr2024 0700 CETCEST Release of an ad

Kuros biosciencesLeadership teamDrug administrationBusiness developmentKuros medical devicesMagnetos puttyJoe rossSenior vice presidentChris fair

Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales

Kuros Biosciences AG / Key word: Quarter Results/Regulatory Approval Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales 24-Apr-2024 / 07:00.

Kuros biosciencesDrug administrationBusiness developmentLeadership teamKuros medical devicesMagnetos puttyJoe rossSenior vice presidentChris fair